Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2024Journal of Medical Virology

Enhanced prognostic evaluation of diffuse large B‐cell lymphoma: A comprehensive surveillance study incorporating Epstein–Barr virus infection status and immunohistochemical markers

View Full Paper
Ask AI
Bookmark
Share

Authors

MZMeichun ZengFirst Affiliated Hospital Zhejiang UniversityQJQingjun JiaHangzhou Center for Disease Control and PreventionJCJingjing ChenNingbo University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zeng et al. (2024) studied this question.

synapsesocial.com/papers/68e5dd94b6db6435875731d2https://doi.org/10.1002/jmv.29834
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The 2016 revision of the World Health Organization classification of lymphoid neoplasms2016 · 7,965 citations
  2. 2The impact of cell-of-origin, MYC/Bcl-2 dual expression and MYC rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy2021 · 11 citations
  3. 3The BCL‐2 family protein inhibitor ABT‐737 as an additional tool for the treatment of EBV‐associated post‐transplant lymphoproliferative disorders2020 · 19 citations
  4. 4Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma2022 · 45 citations